Activity of Sorafenib plus Capecitabine (SorCape) in Previously Treated Metastatic Colorectal Cancer.

CONCLUSION: SorCape in this heavily pre-treated population yielded a reasonable PFS with manageable, but notable toxicity. The combination should be investigated further.
PMID: 33512054 [PubMed - as supplied by publisher]

Source: The Oncologist - January 29, 2021 Category: Cancer & Oncology Authors: George TJ, Ivey AM, Ali A, Lee JH, Wang Y, Daily KC, Ramnaraign BH, Tan SA, Terracina KP, Read TE, Dang LH, Iqbal A Tags: Oncologist Source Type: research